| 1 | HARP, PANK2, PKAN
|
| PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
|
| Matarin MM, Singleton AB, Houlden H.
|
| Neurosci Lett 407(2):162-5. Epub 2006 Sep 7. 2006
|
| 2 | HARP, PANK2, PKAN
|
| Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic.
|
| Houlden H, Lincoln S, Farrer M, Cleland PG, Hardy J, Orrell RW.
|
| Neurology 61(10):1423-6. 2003
|
| 3 | HARP, PANK2, PKAN
|
| HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration.
|
| Ching KH, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ.
|
| Neurology 58(11):1673-4. 2002
|
| 4 | HARP, PANK2
|
| Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome).
|
| Orrell RW, Amrolia PJ, Heald A, Cleland PG, Owen JS, Morgan-Hughes JA, Harding AE, Marsden CD.
|
| Neurology 45(3 Pt 1):487-92.
1995
|
| 5 | HARP, PANK2, PKAN
|
| Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome).
|
| Higgins JJ, Patterson MC, Papadopoulos NM, Brady RO, Pentchev PG, Barton NW.
|
| Neurology 42(1):194-8. 1992
|